Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KCNA3 | P22001 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.82 |
| ▸ | TP53 | P04637 | 1/20 | 0.82 |
| ▸ | ATM | Q13315 | 1/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.82 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.73 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.73 |
| ▸ | MAOA | P21397 | 2/20 | 0.72 |
| ▸ | MAOB | P27338 | 2/20 | 0.72 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | DPP4 | P27487 | 1/20 | 0.67 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cardamomin SCHEMBL30891551 | 1.00 | MAPT (1.00) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| Cardamomin SCHEMBL1939236 | 1.00 | MAPT (1.00) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| Cardamomin SCHEMBL25194293 | 1.00 | MAPT (1.00) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| SCHEMBL25203552 | 0.93 | MAPT (0.86) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| SCHEMBL25203549 | 0.93 | MAPT (0.86) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| SCHEMBL2289898 | 0.92 | MAPT (0.85) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| SCHEMBL2289891 | 0.92 | MAPT (0.85) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| Flavokawain B SCHEMBL25185055 | 0.90 | MAPT (1.00) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| Flavokawain B SCHEMBL1675987 | 0.90 | MAPT (1.00) | MAPTKMT2ANPSR1MEN1KCNA3 | |
| Flavokawain B SCHEMBL30382640 | 0.90 | MAPT (1.00) | MAPTKMT2ANPSR1MEN1KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 924 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087695-A1 | TREATMENT FOR METABOLIC DISORDER | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| US-12485090-B1 | Compositions, uses and methods for making them | ELBOGEN STEVEN (US) | 2025-12-02 | — | — | US | claimed |
| EP-4627058-A1 | METHODS AND COMPOSITIONS FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND DERIVED NATURAL KILLER CELLS | Nuwacell Biotechnologies Co., Ltd. (CN) | 2025-10-08 | — | — | EP | claimed |
| EP-4627061-A1 | CULTURE MEDIUM, COATING MATRIX AND METHOD FOR MATURING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS | Nuwacell Biotechnologies Co., Ltd. (CN) | 2025-10-08 | — | — | EP | claimed |
| US-12391919-B2 | Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2025-08-19 | — | — | US | claimed |
| US-20250207092-A1 | CULTURE MEDIUM, COATING MATRIX AND METHOD FOR MATURING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2025-06-26 | — | — | US | claimed |
| CN-120131942-A | Application of immune cells and traditional Chinese medicine formula in preparation of cancer treatment medicines | 中泽赛奥(海南)生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-113365513-B | Compositions and methods for treating lung | G·E·霍格 | 2025-04-25 | — | — | CN | claimed |
| CN-119667008-A | Construction method and application of fingerprint of semen Alpiniae medicinal material, standard decoction and traditional Chinese medicine formula granule thereof | 广东一方制药有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-103271891-A | Ginsenoside nano-micelle, and preparation method, application and pharmaceutical composition thereof | FUJIAN SOUTH PHARMACEUTICAL CO LTD | 2013-09-04 | — | — | CN | claimed |
| CN-102107006-A | Coupling medicament for treating diabetes mellitus and medicinal application thereof | CHIFCON DRUG DISCOVERY SUZHOU INC | 2011-06-29 | — | — | CN | claimed |
| CN-102107009-A | Mixed compound medicament of natural medicament components and nitric oxide donors and application thereof | CREATING HEALTH FOR YOU THROUGH INNOVATION | 2011-06-29 | — | — | CN | claimed |
| CN-102000072-A | Anti-tumor natural medicine coupled with nitric oxide donor and medical use thereof | QIFUKANG DRUG RES AND DEV SUZHOU CO LTD | 2011-04-06 | — | — | CN | claimed |
| CN-101973863-A | Method for extracting cardamomin from alpinia katsumadai | NANJING ZELANG MEDICAL TECH CO | 2011-02-16 | — | — | CN | claimed |
| CN-101168009-B | Quality control method of macaque stone bovinebezoar powder | GUANGZHOU QIXING PHARMACY GROUP CO LTD | 2010-10-06 | — | — | CN | claimed |
| WO-2010053340-A2 | SKIN-WHITENING COMPOSITION | 주식회사 알엔에스 (KR) | 2010-05-14 | — | — | WO | claimed |
| CN-101612098-A | The purposes of cardamonin in preparation skin-lightening cosmetic or medicine | SHANGHAI INOHERB COSMETICS CO | 2009-12-30 | — | — | CN | claimed |
| CN-101168009-A | Quality control method of macaque stone bovinebezoar powder | GUANGZHOU QIXING PHARMACY GROU (CN) | 2008-04-30 | — | — | CN | claimed |
| CN-200963950-Y | Postcard with telephone card | BEIJING HUAYI DASHIJIE ADVERTI (CN) | 2007-10-24 | — | — | CN | claimed |